Accelerating impact
Imperial announces improved Founders Choice programme for spinout companies
Imperial has made important improvements to Founders Choice, its spinout formation and support approach.
Imperial announces improved Founders Choice programme for spinout companies
Imperial has made important improvements to Founders Choice, its spinout formation and support approach.
Celebrating Imperial’s enterprising community at the Big Summer Social
Imperial’s innovators, creators and impact-makers marked an impressive year for the College’s Enterprise Ecosystem at the Big Summer Social last week.
Steps to healthcare company partnering examined at Sir Michael Uren Hub
Imperial’s White City Campus hosted the London hub of an international educational workshop held by Johnson & Johnson Innovation.
UK universities and VC investors launch USIT guide to accelerate spinout success
The UK's potential as a science super-power was boosted today with the launch of expert guidance on investment terms for university spinouts.
Translational support for impact on show at All You Can Innovate 2023
Professor Thrishantha Nanayakkara has a vision for palm tree farmers – a technology-enabled approach to precision agriculture and harvesting.
MintNeuro: redefining neurological interventions with bioelectronic implants
A new generation of bioelectronic implants created by Imperial spinout MintNeuro could transform treatment of neurological conditions.
£1.6 million raised for Parkinson’s Disease continuous monitoring technology
Imperial startup SERG Technologies has raised funds to further develop its technology to monitor and optimise treatment of Parkinson's.
Imperial and Allocate Software collaborate on safer staffing tools
Imperial has signed a deal with Allocate, a rostering software provider, to make proven patient acuity models available through SafeCare®.
Data-driven research partnership aims to identify predictive disease markers
Imperial College London and SomaLogic will combine research expertise with the aim of uncovering predictive biomarkers for cancer and other diseases
Fuel cell disruptor Bramble Energy raises £35 million
An Imperial startup whose technology could help kickstart the hydrogen economy has raised £35 million from investors.